Welcome
Join us as we explore the future of antimicrobials from a multipronged approach. In this live webinar, we will highlight the complexity of demonstrating the value of antimicrobials and discuss how risk-sharing agreements and managed entry agreements affect innovation. Finally, you can join the discussion as we review the importance of value, innovation and collaboration in tackling antimicrobial resistance.
Our Faculty

Lieven Annemans
 Senior Professor of Health Economics,
 Ghent University, Ghent, Belgium, and 
Guest Professor at the Vienna 
School of Clinical Research, Vienna, Austria 

Mark Gilchrist
 Consultant Pharmacist in Infectious
 Diseases, Imperial College Healthcare
 NHS Trust, London, UK 

Alec Morton
 Visiting Professor, Saw Swee Hock
 School of Public Health, National 
University of Singapore, Singapore 
Agenda
Managed entry agreements
moderated by Alec Morton (Singapore)
moderated by Alec Morton (Singapore)
Why attend HIVE?
The goal of the HIVE programme is to provide a platform for hospital pharmacists, payers and key decision-makers to expand their knowledge of health economics and outcomes research as well as health technology assessments in order to assessments in order to assess the impact of antimicrobial resistance and the value of anti-infectives. The programme will also consider how application of this can improve appropriate patient access to effective anti-infective therapies.


